论文部分内容阅读
目的总结酒精性肝病的治疗体会。方法选取78例酒精性肝病住院患者的临床资料,分析其治疗方案及效果。结果戒酒同时还原性谷胱甘肽、多烯磷脂酰胆碱的护肝治疗同未能戒酒治疗疗效,肝功能指标和肝纤维化指标均较治疗前下降,组间比较差异有统计学意义(P<0.05)。治疗期间有15例(19.29%)患者出现不同程度酒精戒断症状。结论对于酒精性肝病的治疗,在尽量减少肝脏负担的前提下,戒酒同时联合护肝治疗效果良好,在治疗过程中应及时发现并治疗可能出现的酒精戒断综合征。
Objective To summarize the experience of alcoholic liver disease. Methods The clinical data of 78 hospitalized patients with alcoholic liver disease were selected and the treatment plan and effect were analyzed. Results Abstinence alcohol and reducing glutathione, polyene phosphatidylcholine treatment of liver with the same treatment failed to abstinence, liver function indicators and liver fibrosis index decreased compared with before treatment, there were statistically significant differences between groups Significance (P <0.05). During treatment, 15 patients (19.29%) showed different degrees of alcohol withdrawal symptoms. Conclusions For the treatment of alcoholic liver disease, abstinence combined with hepatoprotective therapy is effective in minimizing the burden on the liver. In the course of treatment, probable alcohol withdrawal syndrome should be found and treated in time.